Lexology January 31, 2025
Several members of our firm’s life sciences team were on the ground at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco from January 13 to 16, 2025. It was an exciting and sunny four days, during which key players from across the life sciences industry gathered to engage in deal discussions and consider upcoming trends for the pharmaceutical, biotechnology, and healthcare industries. Although there was a notable increase in the level of security at the conference given recent events, the overall sentiment of the conference was one of optimism.
Below are our key takeaways in the areas of US Food and Drug Administration (FDA) regulation, pricing and reimbursement, and corporate transactions from the events surrounding the conference. This...
Today's Sponsors
Today's Sponsor